AbbVie Stake Changes and Strong Q2 Results Lift Investor Sentiment
Calamos Advisors LLC increased its AbbVie position by 3.4% in the fourth quarter, while Axecap Investments LLC and other holders adjusted stakes. Meadowbrook Wealth Management LLC cut its holding by 37.3% in the second quarter. AbbVie also reported strong second-quarter results, with revenue up 10.2% year over year and adjusted EPS of $3.65, beating consensus by $0.04.